NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)
Details
- Buyer
- NHS England
- Supplier(s)
63 suppliers
- Accord UK Ltd
- AOP Orphan Ltd
- Arcadia Pharma Limited T/A Arcadia Medical
- Ascend Laboratories (UK) Limited
- Aspen Pharmacare UK Limited
- Baxter Healthcare Ltd
- Bayer Public Limited Company
- Beaumont Pharma Ltd
- Bristol Laboratories Ltd
- Brown and Burk
- Chiesi Ltd
- Cipla
- Clydesdale Pharma ltd
- Correvio GmbH
- Crescent Pharma Limited
- Derma UK
- Dr Falk Pharma UK Ltd
- DRUGSRUS LIMITED
- Eramol (UK) Ltd
- Evolan Pharma
- Ferring Pharmaceutical
- Focus Pharmaceuticals Ltd
- Galen Ltd
- Galvany Pharma Ltd
- Genesis Pharmaceuticals Ltd
- JCSH Pharma Ltd
- Krka UK ltd
- Kyowa Kirin Ltd
- LogixX Pharma Ltd
- Lundbeck Limited
- Lupin Healthcare (UK) Ltd
- Macure Pharma ApS
- Manx Healthcare Ltd
- Medley Pharma Ltd
- MSN Laboratories Europe Limited
- Necessity Supplies Ltd
- Neon Healthcare Ltd
- Norgine Pharmaceuticals Limited
- Oralieve UK Ltd
- Orion Pharma (UK) Ltd
- P M Pharma
- Phoenix Lab
- Reckitt Benckiser
- Recordati Pharmaceuticals Ltd
- Reig Jofre UK Ltd
- RELONCHEM LIMITED
- Rivopharm
- RPH Pharmaceuticals AB
- Scope Ophthalmics Ltd
- Stirling Anglian Pharmaceuticals Ltd
- Strandhaven Limited t/a Berg Pharmacy
- Strides Pharma Uk LTD
- Synchrony
- Syri Limited (T/A Thame Laboratories)
- Takeda UK Limited
- Tetris Pharma Lts
- Thea Pharmaceuticals Ltd
- Tillomed Laboratories Ltd
- Torrent Pharma (UK) Ltd
- Typharm Ltd
- Uni Health Distribution Ltd
- Vantage Pharmaceuticals Ltd
- Waymade plc
- Value
- £1
- Duration
- 3 years
- Topic
- Pharmaceutical products
- Published
- 14 May 2024
- Source
- uk:contracts_finder
Tender description
Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)
Timeline
- Completed: Award published14 May 2024Current notice
- Completed: Award date1 June 2024
- Next: Contract expiry date31 May 2027in 7 months
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
13 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
Injection Equipment Paraphernalia
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 509£240.8m
- 445£6.2bn
- 408£112.0m
- 394£649.4m
- 324£1.2bn
- 321£24.6bn
- 290£1.6bn
- 259£3.1bn
- 163£126.7m
- 150£1.0bn
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.